The genomic medicine Precision medicine will have a transformative impact on personal health and well-being, the healthcare economy, and national productivity, according to researchers at Master's degree in genetics.
In recent years, there has been an extraordinary leap forward in our understanding of the human genome and its role in health and disease. A decade ago, researchers were tentatively exploring the first sequences of the human reference genome, which cost more than one billion dollars to produce.
Thousands of genomes representing a cross-section of ethnic backgrounds have now been sequenced. This surge in activity has been made possible by unprecedented advances in sequencing technologies.
To make sense of genomic data, information technologies and databases must evolve in tandem with sequencing technologies. Advances in both technologies are leading to an ever-increasing capacity for the precise diagnosis of existing diseases and the development of effective and targeted treatment strategies.
They also offer the ability to assess a person's predisposition to the disease, which could lead to more targeted clinical follow-up and lifestyle changes.
Current Applications of Genetics in Medicine
Prenatal screening tests are the most commonly offered; in these tests, fragments of DNA from the placenta, extracted from the mother's blood, to detect genetic abnormalities.
In recent years, cancer therapy has focused on the use of tumor-specific antigens identified through sequencing as targets for biological therapies. For example, the ado-trastuzumab It is a monoclonal combination chemotherapy drug that has reduced the three-year disease-free remission rate in breast cancer by 11.3% compared to the previous standard treatment.
The pharmacogenomics, optimizing drug response based on genetics is another promising emerging field and constitutes a cornerstone of modern genetic medicine.
The Ivacaftor It is a CFTR channel enhancer and the most effective medication for cystic fibrosis currently available on the market; however, it is only suitable for the 4%-5% subgroup of patients who are homozygous for the mutation delta F508. Genetic testing is offered to patients only under specific circumstances, such as a family history of Huntington's disease or a high likelihood of mutations.
Otherwise, patients can obtain paid genetic testing through private biotechnology companies, which sequence patients' genomes to identify specific genes of interest.
Currently, whole-genome sequencing is not widely available to the general public outside of specific research settings. However, the genomics It has a place in modern medicine and is poised to expand significantly in the coming decades.
Clinical leaders envision two main future applications for preventive whole-genome sequencing:
- As a noninvasive screening test for preventive medicine.
- As a test to improve diagnostic capabilities.
In fact, just as the identification of individuals carrying mutations in the genome BRCA1/2 led to prophylactic mastectomy and oophorectomy; early and detailed genomic data would provide valuable insights into the risks of future diseases spanning various medical specialties, from oncology to psychiatry, and would aid in their prevention.
To achieve this feat, the use of Big Data in genomic medicine is being promoted worldwide, where millions of reference sequences, individualized patient factors, and phenotypic expression are collected and combined into a multifactorial database and an algorithm that allows for the comparison of individually sequenced genomes.
To achieve this goal, President Barack Obama launched the “All of Us” by the National Institutes of Health, which called for the collection of one million sequenced genomes, supplemented by environmental factors and demographic information on U.S. citizens. To date, more than 600,000 have been collected. This is a multinational effort.
Countries such as the United Kingdom and China have launched similar initiatives. The Global Alliance for Genomics and Health (GA4GH) predicts that by 2025, 60 million genomes will have been sequenced worldwide.
Just as radiological imaging has increased the positive predictive value of diagnoses based on clinical signs and symptoms and reduced the rates of exploratory surgical procedures, genomics in medicine is poised to further enhance this and add another layer of confidence to diagnostic approaches.
It is fascinating to consider how the growing role of genomics in medicine will affect our understanding and classification of diseases.
Perhaps purely clinical diagnoses, such as trigeminal neuralgia, major depressive disorder, or atopic dermatitis, will be redefined in light of their underlying genetic origins. Ultimately, this will provide a clearer understanding of diseases and improve treatment strategies and research.
Although our understanding of the human genome is far from complete, there are an increasing number of examples that demonstrate that even our limited genomic knowledge can be powerful in clinical practice.
Currently, genome sequencing has the greatest impact on cancer stratification, the characterization of genetic diseases, and information about an individual's likely response to treatment.
Are you interested in any of our services?